Target the bacteria behind acne and odour — not the good ones.

For brand owners, formulators and Global R&D teams.

That is the promise we brought to in-cosmetics Global in Paris, and the one thing brand teams kept coming back to our stand to talk about.

If you build products for acne-prone skin or body odour, this short brief is for you: what makes our approach different, the clinical numbers behind it, and how a Singapore clinic turned it into a real, on-shelf product. Our philosophy in five words: manage the bad, keep the good.

Four things worth your time

Tap any card to read the full story. Two are in the Newsroom, two elsewhere on the site.

The ArrowBiome stand at in-cosmetics Global 2026, Paris

Company · Event recap

A precision message that stopped traffic at in-cosmetics Global Paris

We took one provocation to in-cosmetics Global in Paris — why use blunt antimicrobials on a living microbiome? Over three days it drew 398 company conversations from 53 countries. Here is what brand teams and formulators kept asking about precision microbiome actives, and what it tells us about where the category is heading.

Read the recap

Abstract illustration of a droplet above skin with a balanced microbiome layer beneath

Clinically proven

Why your next acne or odour product needs a rethink

The case for removing only the bacteria driving the problem, backed by human clinical data on both lead actives.

See the evidence

Abstract illustration of a protein structure connected to a network

Inside the platform

How ArrowBiome is building AI into discovery

An AI-native biotech: a compounding data engine that makes every new active faster to find and to design.

Explore the platform

The KINS BioRevive Gel Mask at KINS Clinic, Singapore

Product · From lab to launch

From clinical data to the shelf: the KINS BioRevive Gel Mask

On 20 July 2026 SmartArrow® reached the shelf. KINS Clinic Singapore launched the BioRevive Gel Mask, a rinse-off mask for acne-prone and sensitive skin built on ArrowBiome's precision active and formulated under GMP by CHAKS. Here is how a clinical dataset became a product a customer can hold.

Read the story

Which of your products could go microbiome-precise?

Tell us the format and the claim you are chasing, and we will send the SmartArrow® and ArcherZyme® technical dossier, inclusion guidance and sampling options.

Work with us Contact the team

Clinical figures describe the ingredient as a standalone active in a controlled, dermatologist-supervised study. They are evidence for the ingredient and are not therapeutic claims for the KINS BioRevive Gel Mask or any other finished product.

Sources: ArrowBiome platform and evidence pages; KINS Clinic launch release, 20 July 2026; in-cosmetics Global 2026 organiser attendance as reported by Global Cosmetics News; A*STAR Genome Institute of Singapore, Nature Biotechnology, April 2026.

All news Subscribe by RSS →